Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin in Moderate Brain Trauma
IRCT20221108056446N5Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of melatonin in traumatic brain injury (TBI), sponsored by Isfahan University of Medical Sciences. Started Dec 2023; status: completed.
02
Drugs
melatonin
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on IRCT20221108056446N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221108056446N5.